News

In partnership with the University of Alabama at Birmingham (UAB) Medicine, patients will consult with UAB maternal-fetal medicine physicians while continuing to receive care from their local obstetrics and gynecology (OB-GYN) providers.

Prostate cancer is the No. 2 leading cause of cancer death in American men, second only to lung cancer. An estimated 333,830 men will be diagnosed with prostate cancer in the United States in 2026, and about 1 in 44 of all men will die from it, according to the American Cancer Society.

For many women, menopause brings unwanted side effects that can impact their physical health, mental health and quality of life. These bothersome symptoms can range from hot flashes and night sweats to mood changes, dry eyes and strange occurrences such as a burning tongue.

Hormone therapy during menopause can reduce hot flashes, night sweats, and other symptoms that impact a woman’s quality of life, including certain vaginal issues. It also can help prevent bone loss.

However, hormone therapy – often called hormone replacement therapy (HRT) – has a confusing history when it comes to cardiovascular health. UAB Medicine cardiologist Gretchen Wells, M.D., explains how changing interpretations of research have left some women unsure whether they can safely use this proven treatment.

Pankaj Arora M.D., professor of medicine in the Division of Cardiovascular Disease at the University of Alabama at BirminghamMarnix E. Heersink School of Medicine and director of the UAB Cardiovascular Genetics Clinic, has received a five-year R01 grant from the National Heart, Lung, and Blood Institute to investigate how genetic differences in natriuretic peptide levels influence blood pressure and an individual’s response to dietary salt.

Through the Lawson State Community College Medical Radiologic Technology Program at UAB Medicine, participants enroll in Lawson State’s Associate in Applied Science degree program while completing instructional and clinical training on-site at UAB Hospital. Upon graduation, participants will commit to work in eligible radiologic technologist roles at UAB Medicine.

Up to 70 percent of women with high-grade ovarian cancer see their cancer return after surgery and platinum-based chemotherapy. A new clinical trial at the University of Alabama at Birmingham is testing an investigational treatment that could eventually offer a new way to fight the disease.

UAB Medicine has once again been named one of the nation’s leaders in the use of information technology in health care by the College of Healthcare Information Management Executives. Both the University of Alabama at Birmingham Hospital and UAB Medicine’s ambulatory clinics were cited for achieving Level 8 status in CHIME’s 2026 Digital Health Most Wired survey.

Jennifer Parker is an advocate for organ donation and breast cancer awareness. With 35 years of professional experience in healthcare, she is a compelling public speaker and tireless ambassador for patient-centered care.

For professional soccer players, every match is an opportunity to make an impact. But when a season is interrupted by an injury, success starts being measured not by goals and wins, but by the determination to return stronger than before.

Regular physician visits and medical screenings are critical to maintaining one’s health. However, women are often unsure about what tests they need and at what age, which doctors they should be seeing annually, and what physiological changes they may experience at certain ages.

Two of the University of Alabama at Birmingham’s key brand drivers, UAB Athletics and UAB Medicine, announced an expanded five-year partnership Monday that will significantly increase UAB Medicine’s presence across Blazer Athletics, including new branding on select UAB uniforms and competition equipment.